Current Pharmaceutical Biotechnology

Editor-in-Chief:

Davide Prosperi
Department of Biotechnology and Bioscience
University of Milan Bicocca
Milano
Italy

Back

Become EABM
Become Reviewer

Editorial [Hot Topic: Relevance of Pharmacokinetics to Antibiotic Dosing in Critically Ill Patients (Guest Editor: Jason A. Roberts)] promotion: free to download

Volume:12   Issue: 12
Pp: 1981-1982
Jason A. Roberts
DOI: 10.2174/138920111798808310

Pharmacokinetic Concepts Revisited - Basic and Applied

Volume:12   Issue: 12
Pp: 1983-1990
Kashyap Patel and Carl M.J. Kirkpatrick
DOI: 10.2174/138920111798808400

Physiological Changes in the Critically Ill Patient with Sepsis

Volume:12   Issue: 12
Pp: 1991-1995
Shaun Hosein, Andrew A. Udy and Jeffrey Lipman
DOI: 10.2174/138920111798808248

The Relevance of Drug Volume of Distribution in Antibiotic Dosing

Volume:12   Issue: 12
Pp: 1996-2001
Marta Ulldemolins and Jordi Rello
DOI: 10.2174/138920111798808365

Dosing of Antibiotics in Critically Ill Patients Undergoing Renal Replacement Therapy

Volume:12   Issue: 12
Pp: 2015-2019
Jan T. Kielstein and Olaf Burkhardt
DOI: 10.2174/138920111798808275

ARC - Augmented Renal Clearance

Volume:12   Issue: 12
Pp: 2020-2029
Andrew A. Udy, Michael T. Putt, Robert J. Boots and Jeffrey Lipman
DOI: 10.2174/138920111798808446

The Effect of Critical Illness on Drug Distribution

Volume:12   Issue: 12
Pp: 2030-2036
Daniel Gonzalez, Daniela J Conrado, Ursula Theuretzbacher and Hartmut Derendorf
DOI: 10.2174/138920111798808211

How to Measure Pharmacokinetics in Critically Ill Patients?

Volume:12   Issue: 12
Pp: 2037-2043
Xin Liu, Peter S. Kruger and Michael S. Roberts
DOI: 10.2174/138920111798808239

Relevance of Pharmacokinetic and Pharmacodynamic Modeling to Clinical Care of Critically Ill Patients

Volume:12   Issue: 12
Pp: 2044-2061
Jurgen B. Bulitta, Cornelia B. Landersdorfer, Alan Forrest, Silvia V. Brown, Michael N. Neely, Brian T. Tsuji and Arnold Louie
DOI: 10.2174/138920111798808428

Reducing the Development of Antibiotic Resistance in Critical Care Units

Volume:12   Issue: 12
Pp: 2062-2069
Marjolein P.D. Deege and David L. Paterson
DOI: 10.2174/138920111798808301

Editorial [Hot Topic: TGF-β As Target in Oncology (Guest Editor: Karl-Hermann Schlingensiepen)] promotion: free to download

Volume:12   Issue: 12
Pp: 2080-2080
Karl-Hermann Schlingensiepen
DOI: 10.2174/138920111798808220

Biology of Transforming Growth Factor-β Signaling

Volume:12   Issue: 12
Pp: 2099-2107
Hiroaki Ikushima and Kohei Miyazono
DOI: 10.2174/138920111798808419

TGF-β Receptor Signaling Pathways in Angiogenesis; Emerging Targets for Anti-Angiogenesis Therapy

Volume:12   Issue: 12
Pp: 2108-2120
Laurens A. van Meeteren, Marie-Jose Goumans and Peter ten Dijke
DOI: 10.2174/138920111798808338

Therapeutic Strategies to Target TGF-β in the Treatment of Bone Metastases

Volume:12   Issue: 12
Pp: 2121-2137
Jeroen T. Buijs, Patricia Juarez and Theresa A. Guise
DOI: 10.2174/138920111798808293

The Complexities of TGF-β Action During Mammary and Squamous Cell Carcinogenesis

Volume:12   Issue: 12
Pp: 2138-2149
Erin C. Connolly and Rosemary J. Akhurst
DOI: 10.2174/138920111798808284

TGF-β2 Signaling in High-Grade Gliomas

Volume:12   Issue: 12
Pp: 2150-2157
Peter Hau, Piotr Jachimczak, Jurgen Schlaier and Ulrich Bogdahn
DOI: 10.2174/138920111798808347

Transforming Growth Factor Beta in Pancreatic Cancer

Volume:12   Issue: 12
Pp: 2158-2164
Andreas Hilbig and Helmut Oettle
DOI: 10.2174/138920111798808356

Role of TGF-β in Melanoma

Volume:12   Issue: 12
Pp: 2165-2175
A. Busse and U. Keilholz
DOI: 10.2174/138920111798808437

Antibody Targeting of TGF-β in Cancer Patients open access plus

Volume:12   Issue: 12
Pp: 2176-2189
Scott Lonning, Joan Mannick and John M. McPherson
DOI: 10.2174/138920111798808392

TGF-Beta Type I Receptor (Alk5) Kinase Inhibitors in Oncology

Volume:12   Issue: 12
Pp: 2190-2202
Leona E. Ling and Wen-Cherng Lee
DOI: 10.2174/138920111798808257

The Antisense Oligonucleotide Trabedersen (AP 12009) for the Targeted Inhibition of TGF-β2

Volume:12   Issue: 12
Pp: 2203-2213
Frank Jaschinski, Tanja Rothhammer, Piotr Jachimczak, Christian Seitz, Anneliese Schneider and Karl-Hermann Schlingensiepen
DOI: 10.2174/138920111798808266